DalsnaFinance › IPOs › Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. completed its initial public offering on NASDAQ on January 28, 2025, pricing at $10.00 a share.
| Ticker | DMAAU |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 28, 2025 |
| Offering price | $10.00 |
| Shares offered | 20,000,000 |
| Total raised | $200M |
IPO data is compiled from SEC filings. This page is general information, not investment advice.